I. Bernard Weinstein

I. Bernard Weinstein's AcademicInfluence.com Rankings

Philosophy

#2428

World Rank

#4158

Historical Rank

Logic

#695

World Rank

#1205

Historical Rank

philosophy Degrees

Download Badge

Philosophy

I. Bernard Weinstein's Degrees

Bachelors Chemistry University of Texas at Austin

Why Is I. Bernard Weinstein Influential?

(Suggest an Edit or Addition)

According to Wikipedia, I. Bernard Weinstein was an American physician and researcher who studied the effect of pollutants and other environmental factors in causing cancer and headed the Comprehensive Cancer Center at Columbia University. He has been credited with helping create the field of molecular epidemiology, which studies how genetic and environmental risk factors are related to the spread of disease in populations.

(See a Problem?)

I. Bernard Weinstein's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Addiction to Oncogenes--the Achilles Heal of Cancer (2002) (1683)
Mechanisms of Disease: oncogene addiction—a rationale for molecular targeting in cancer therapy (2006) (714)
Oncogene addiction. (2008) (663)
Benzo(a)pyrene diol epoxides as intermediates in nucleic acid binding in vitro and in vivo. (1976) (568)
Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. (2002) (489)
Inhibition of protein kinase C by tamoxifen. (1985) (481)
Overproduction of protein kinase C causesdisordered growth control in rat fibroblasts (1988) (451)
Amplification and expression of the human cyclin D gene in esophageal cancer. (1992) (450)
Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. (2002) (401)
Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. (1993) (397)
Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. (1993) (389)
Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. (1996) (351)
The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment--twenty-seventh G.H.A. Clowes memorial award lecture. (1988) (341)
(−)-Epigallocatechin Gallate and Polyphenon E Inhibit Growth and Activation of the Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor-2 Signaling Pathways in Human Colon Cancer Cells (2005) (333)
Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. (2001) (329)
Tumor-promoting phorbol esters inhibit binding of epidermal growth factor to cellular receptors. (1978) (329)
Tumour promotor induces plasminogen activator (1976) (301)
Molecular epidemiology and carcinogen-DNA adduct detection: new approaches to studies of human cancer causation. (1982) (300)
Structures of benzo(a)pyrene–nucleic acid adducts formed in human and bovine bronchial explants (1977) (299)
Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer. (1989) (296)
Multiple functions of p27Kip1 and its alterations in tumor cells: a review (2000) (295)
Novel Roles of Specific Isoforms of Protein Kinase C in Activation of the c-fos Serum Response Element (1999) (293)
Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. (1997) (245)
Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. (1993) (245)
Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. (2002) (240)
Mitochondrial DNA is a major cellular target for a dihydrodiol-epoxide derivative of benzo[a]pyrene. (1980) (237)
Tumor promoters inhibit spontaneous and induced differentiation of murine erythroleukemia cells in culture. (1977) (235)
The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. (1993) (226)
Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis. (2000) (222)
Molecular epidemiology: recent advances and future directions. (2000) (221)
Localization and expression of p27KIP1 in multistage colorectal carcinogenesis. (1998) (215)
Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines. (1999) (209)
Roles of Specific Isoforms of Protein Kinase C in the Transcriptional Control of Cyclin D1 and Related Genes* (2003) (207)
Rapid and sensitive nonradioactive detection of mutant K-ras genes via 'enriched' PCR amplification. (1991) (202)
Overexpression of protein kinase C in HT29 colon cancer cells causes growth inhibition and tumor suppression (1990) (196)
Action of phorbol esters in cell culture: mimicry of transformation, altered differentiation, and effects on cell membranes. (1979) (185)
The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells. (2007) (184)
Bioactive novel polyphenols from the fruit of Manilkara zapota (Sapodilla). (2003) (182)
Prevention of cancer in the next millennium: Report of the Chemoprevention Working Group to the American Association for Cancer Research. (1999) (178)
PKC epsilon functions as an oncogene by enhancing activation of the Raf kinase. (1996) (170)
Amplification of the EGF receptor and c‐myc genes in human esophageal cancers (1988) (167)
BENZO(A)PYRENE-NUCLEIC ACID DERIVATIVE FOUND IN VIVO- STRUCTURE OF A BENZO(A)PYRENETETRAHYDRODIOL EPOXIDE-GUANOSINE ADDUCT (1976) (167)
A pilot project in molecular cancer epidemiology: determination of benzo[a]pyrene--DNA adducts in animal and human tissues by immunoassays. (1982) (166)
Nucleoside adducts from the in vitro reaction of benzo[a]pyrene-7,8-dihydrodiol 9,10-oxide or benzo[a]pyrene 4,5-oxide with nucleic acids. (1977) (163)
Quantitation of benzo(a)pyrene-deoxyguanosine adducts by radioimmunoassay. (1980) (157)
Induction of apoptosis by the garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH(2)-terminal kinase 1 activation. (2003) (154)
Cyclic GMP mediates apoptosis induced by sulindac derivatives via activation of c-Jun NH2-terminal kinase 1. (2000) (153)
Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. (2003) (152)
A preparative method for obtaining enucleated mammalian cells. (1975) (152)
Increased expression of cyclin D1 in a murine mammary epithelial cell line induces p27kip1, inhibits growth, and enhances apoptosis. (1996) (152)
Triphenylethylenes: a new class of protein kinase C inhibitors. (1986) (152)
Bioactive depsides and anthocyanins from jaboticaba (Myrciaria cauliflora). (2006) (149)
Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. (1995) (145)
Production of diacylglycerol, an activator of protein kinase C, by human intestinal microflora. (1990) (140)
Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas. (1995) (139)
Construction and characterization of a retroviral vector demonstrating efficient expression of cloned cDNA sequences. (1988) (137)
Altered levels of protein kinase C and Ca2+-dependent protein kinases in human colon carcinomas. (1987) (136)
Test for malignant transformation of rat liver cells in culture: cytology, growth in soft agar, and production of plasminogen activator. (1977) (135)
Disorders in cell circuitry associated with multistage carcinogenesis: exploitable targets for cancer prevention and therapy. (1997) (134)
Exisulind (sulindac sulfone) suppresses growth of human prostate cancer in a nude mouse xenograft model by increasing apoptosis. (1999) (134)
EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells. (2005) (134)
Interaction of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) with nucleic acids and proteins in vivo and in vitro. (1972) (134)
Antiproliferative effects of S-allylmercaptocysteine on colon cancer cells when tested alone or in combination with sulindac sulfide. (2001) (133)
Monoclonal antibodies to DNA modified by a benzo[a]pyrene diol epoxide. (1984) (128)
Bioactive benzophenones from Garcinia xanthochymus fruits. (2005) (128)
Increased expression of the cyclin D1 gene in Barrett's esophagus. (1996) (128)
Tumor promoters inhibit morphological differentiation in cultured mouse neuroblastoma cells. (1978) (128)
Modulation of signal transduction by tea catechins and related phytochemicals. (2005) (128)
Epidermal growth factor, like phorbol esters, induces plasminogen activator in HeLa cells (1978) (127)
Isolation of cDNA clones encoding protein kinase C: evidence for a protein kinase C-related gene family. (1987) (127)
Expression of four protein kinase C isoforms in rat fibroblasts. Distinct subcellular distribution and regulation by calcium and phorbol esters. (1992) (127)
Quantitative associations between DNA damage in human placenta and maternal smoking and birth weight. (1988) (127)
Overexpression of cyclin D1 enhances gene amplification. (1996) (126)
Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1. (2002) (126)
Mitogenesis is only one factor in carcinogenesis. (1991) (124)
Growth factors, oncogenes, and multistage carcinogenesis (1987) (124)
Similarity of teleocidin B and phorbol ester tumour promoters in effects on membrane receptors (1981) (123)
Effects of antiinflammatory agents on mouse skin tumor promotion, epidermal DNA synthesis, phorbol ester-induced cellular proliferation, and production of plasminogen activator. (1977) (120)
Cancer prevention: recent progress and future opportunities. (1991) (119)
Activation of Protein Kinase G Is Sufficient to Induce Apoptosis and Inhibit Cell Migration in Colon Cancer Cells (2004) (119)
Mechanism of tumor promoter inhibition of cellular binding of epidermal growth factor. (1979) (117)
Deletion of histidine triad nucleotide-binding protein 1/PKC-interacting protein in mice enhances cell growth and carcinogenesis (2003) (116)
Helicobacter pylori inhibits the G1 to S transition in AGS gastric epithelial cells. (1999) (113)
Structure of the fluorescent Y base from yeast phenylalanine transfer ribonucleic acid. (1970) (113)
Growth and structural properties of epithelial cell cultures established from normal rat liver and chemically induced hepatomas. (1975) (113)
Current concepts and controversies in chemical carcinogenesis. (1981) (111)
Cytotoxic chalcones and antioxidants from the fruits of a Syzygium samarangense (Wax Jambu). (2008) (110)
Analysis of type 5 adenovirus transformation with a cloned rat embryo cell line (CREF). (1982) (109)
EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells. (2008) (109)
Two Closely Related Isoforms of Protein Kinase C Produce Reciprocal Effects on the Growth of Rat Fibroblasts (1995) (109)
Effect of N-2-acetylaminofluorene modification on the conformation of nucleic acids. (1974) (108)
The regulation of protein kinase C by chenodeoxycholate, deoxycholate and several structurally related bile acids. (1987) (108)
TREK-1 is a novel molecular target in prostate cancer. (2008) (108)
Effects of combined treatment with interferon and mezerein on melanogenesis and growth in human melanoma cells. (1985) (107)
Three-dimensional structure of human protein kinase C interacting protein 1, a member of the HIT family of proteins. (1996) (105)
Effects of a series of organosulfur compounds on mitotic arrest and induction of apoptosis in colon cancer cells (2005) (103)
Hint1 is a haplo-insufficient tumor suppressor in mice (2006) (102)
Regulation of Airway Epithelial Cell NF-κB-Dependent Gene Expression by Protein Kinase Cδ1 (2003) (102)
Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. (1995) (101)
Identification of receptors for phorbol ester tumor promoters in intact mammalian cells and of an inhibitor of receptor binding in biologic fluids. (1981) (100)
EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells. (2005) (99)
Interactions between adenovirus, a tumor promoter, and chemical carcinogens in transformation of rat embryo cell cultures. (1978) (98)
Effects of overexpression of ornithine decarboxylase (ODC) on growth control and oncogene-induced cell transformation. (1991) (96)
Induction of the Z conformation in poly(dG-dC).poly(dG-dC) by binding of N-2-acetylaminofluorene to guanine residues. (1981) (96)
Absolute configuration of a ribonucleic acid adduct formed in vivo by metabolism of benzo[a]pyrene. (1977) (95)
Growth Inhibitory Activity of Extracts and Purified Components of Black Cohosh on Human Breast Cancer Cells (2004) (94)
Differential excision from DNA of the C-8 and N2 guanosine adducts of N-acetyl-2-aminofluorene by single strand-specific endonucleases. (1977) (93)
Detection of carcinogen–DNA adducts by radioimmunoassay (1977) (91)
LACK OF FIDELITY IN THE TRANSLATION OF SYNTHETIC POLYRIBONUCLEOTIDES. (1964) (90)
Overexpression of cyclin D1 occurs in both squamous carcinomas and adenocarcinomas of the esophagus and in adenocarcinomas of the stomach. (1999) (90)
Oncogene-induced transformation of C3H 10T1/2 cells is enhanced by tumor promoters. (1984) (90)
Cyclin-dependent kinase 6 associates with the androgen receptor and enhances its transcriptional activity in prostate cancer cells. (2005) (89)
Cells that overproduce protein kinase C are more susceptible to transformation by an activated H-ras oncogene (1989) (89)
Deregulated expression of p27(Kip1) in human breast cancers. (1997) (89)
Protein Kinase G Activates the JNK1 Pathway via Phosphorylation of MEKK1* (2001) (87)
(-)-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser1046/1047 by p38 MAPK in colon cancer cells. (2009) (87)
Electric linear dichroism study on the orientation of benzo[alpha]pyrene-7,8-dihydrodiol 9,10-oxide covalently bound to DNA. (1978) (86)
Activation of rat brain protein kinase C by lipid oxidation products. (1988) (86)
Expression of cyclins D1 and E in human colon adenocarcinomas. (1997) (85)
Benzodiazepines have high-affinity binding sites and induce melanogenesis in B16/C3 melanoma cells. (1981) (85)
Different Protein Kinase C Isoforms Determine Growth Factor Specificity in Neuronal Cells (2000) (84)
Role of COX-independent targets of NSAIDs and related compounds in cancer prevention and treatment. (2003) (84)
Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors (1998) (84)
Expression of four protein kinase C isoforms in rat fibroblasts. Differential alterations in ras-, src-, and fos-transformed cells. (1992) (83)
Specific and direct binding of protein kinase C to an immobilized tamoxifen analogue. (1988) (83)
Summary of a scientific conference on preventive nutrition: pediatrics to geriatrics. (1999) (82)
Increased expression of cyclin D1 and the Rb tumor suppressor gene in c-K-ras transformed rat enterocytes. (1996) (82)
Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-β1-dependent pathway (2002) (81)
Effect of phorbol ester tumor promoters on the expression of melanogenesis in B-16 melanoma cells. (1979) (81)
Conformation of DNA modified with a dihydrodiol epoxide derivative of benzo[a]pyrene. (1977) (81)
Formation of DNA adducts in 10T1/2 mouse embryo fibroblasts incubated with benzo(a)pyrene or dihydrodiol oxide derivatives. (1979) (80)
(-)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells. (2008) (80)
Tumor promoters induce membrane changes detected by fluorescence polarization. (1979) (79)
Interaction of benzo(a)pyrene and its dihydrodiol-epoxide derivative with nuclear and mitochondrial DNA in C3H10T 1/2 cell cultures. (1982) (79)
Isolation and structure determination of the fluorescent base from bovine liver phenylalanine transfer ribonucleic acid. (1973) (79)
Increased susceptibility to carcinogen-induced mammary tumors in MMTV-Cdc25B transgenic mice (1999) (79)
DNA and RNA adducts formed in hamster embryo cell cultures exposed to benzo[a]pyrene. (1978) (79)
Membrane effects of tumor promoters: Stimulation of sugar uptake in mammalian cell cultures (1979) (79)
Tumor promoters and epidermal growth factor stimulate anchorage-independent growth of adenovirus-transformed rat embryo cells (1979) (78)
Ultraviolet light induces the expression of oncogenes in rat fibroblast and human keratinocyte cells. (1988) (78)
Role of mPKCI, a novel mu-opioid receptor interactive protein, in receptor desensitization, phosphorylation, and morphine-induced analgesia. (2004) (77)
Increased expression of the P27KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1. (1997) (77)
Inhibition of histone acetyltransferase function of p300 by PKCdelta. (2002) (77)
Overexpression of human cyclin D1 reduces the transforming growth factor beta (TGF-beta) type II receptor and growth inhibition by TGF-beta 1 in an immortalized human esophageal epithelial cell line. (1994) (77)
Calcium-dependent activation of protein kinase C. The role of the C2 domain in divalent cation selectivity. (1993) (77)
Measurement of benzo(a)pyrene-DNA adducts by enzyme immunoassays and radioimmunoassay. (1981) (76)
Eukaryotic transposable elements as mutagenic agents (1988) (76)
Vasodilator-stimulated phosphoprotein (VASP) phosphorylation provides a biomarker for the action of exisulind and related agents that activate protein kinase G. (2002) (76)
Comparative effects of overexpression of p27Kip1 and p21Cip1/Waf1 on growth and differentiation in human colon carcinoma cells (1999) (75)
Benzo(a)pyrene-7,8-dihydrodiol 9,10-oxide adenosine and deoxyadenosine adducts: structure and stereochemistry. (1979) (74)
Linking protein kinase C to the cell cycle: ectopic expression of PKC eta in NIH3T3 cells alters the expression of cyclins and Cdk inhibitors and induces adipogenesis. (1996) (74)
Overexpression of protein kinase C beta 1 enhances phospholipase D activity and diacylglycerol formation in phorbol ester-stimulated rat fibroblasts. (1991) (73)
Synergistic effects of RXR&agr; and PPAR&ggr; ligands to inhibit growth in human colon cancer cells—phosphorylated RXR&agr; is a critical target for colon cancer management (2007) (73)
Chronic Helicobacter pylori Infection Induces an Apoptosis-Resistant Phenotype Associated with Decreased Expression of p27kip1 (2000) (72)
Modification of ribonucleic acid by chemical carcinogens. IV. Circular dichroism and proton magnetic resonance studies of oligonucleotides modified with N-2-acetylaminofluorene. (1971) (72)
Expression of retroviral sequences and oncogenes in murine hepatocellular tumors. (1986) (72)
Rearranged c-mos locus in a MOPC 21 murine myeloma cell line and its persistence in hybridomas (1983) (72)
Cellular binding of benzo (a) pyrene to DNA characterized by low temperature fluorescence. (1976) (71)
Letter: Benzo[a]pyrene-nucleic acid derivative found in vivo: structure of a benzo[a]pyrenetetrahydrodiol epoxide-guanosine adduct. (1976) (71)
Roles of cyclin D1 and related genes in growth inhibition, senescence and apoptosis (1999) (70)
Paradoxical increase in retinoblastoma protein in colorectal carcinomas may protect cells from apoptosis. (1999) (69)
Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines (1998) (69)
A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytes. (1997) (69)
Hint1 inhibits growth and activator protein-1 activity in human colon cancer cells. (2007) (68)
Fractionation of rat liver transfer ribonucleic acid. Isolation of tyrosine, valine, serine, and phenylalanine transfer ribonucleic acids and their coding properties. (1969) (68)
Characterization of PKCI and comparative studies with FHIT, related members of the HIT protein family. (1998) (68)
Immunological quantitation of levels of tissue inhibitor of metalloproteinase-1 in human colon cancer. (1991) (67)
Protein kinase C phosphorylates the synthetic peptide Arg-Arg-Lys-Ala-Ser-Gly-Pro-Pro-Val in the presence of phospholipid plus either Ca2+ or a phorbol ester tumor promoter. (1984) (66)
Phorbol esters stimulate the rapid release of choline from prelabelled cells. (1981) (65)
Codon 61 Mutations in the c‐Harvey‐ras Gene in Mouse Skin Tumors Induced by 7,12‐Dimethylbenz[a]anthracene Plus Okadaic Acid Class Tumor Promoters (1989) (65)
Induction of plasminogen activator in cultured cells by macrocyclic plant diterpene esters and other agents related to tumor promotion. (1978) (65)
Polyphenolic constituents of Actaea racemosa. (2006) (64)
Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors. (1995) (64)
Antisense to Cyclin D1 Inhibits Vascular Endothelial Growth Factor–Stimulated Growth of Vascular Endothelial Cells: Implication of Tumor Vascularization (2006) (63)
Protein Kinase C β Enhances Growth and Expression of Cyclin D1 in Human Breast Cancer Cells (2006) (63)
Binding of [3H]benzo(a)pyrene to natural and synthetic nucleic acids in a subcellular microsomal system. (1975) (63)
Disturbances in growth control and gene expression in a C3H/10T1/2 cell line that stably overproduces protein kinase C. (1989) (62)
Overexpression of cyclin E in the HC11 mouse mammary epithelial cell line is associated with growth inhibition and increased expression of p27(Kip1). (1996) (62)
Stat3 orchestrates tumor development and progression: the Achilles' heel of head and neck cancers? (2010) (62)
Effects of phorbol ester tumor promoters on arachidonic acid metabolism in chick embryo fibroblasts. (1979) (62)
Selective translocation of protein kinase C-delta in PC12 cells during nerve growth factor-induced neuritogenesis. (1995) (62)
Nonmutagenic mechanisms in carcinogenesis: role of protein kinase C in signal transduction and growth control. (1991) (62)
Opposing effects of interferon produced in bacteria and of tumor promoters on myogenesis in human myoblast cultures. (1983) (61)
Relevance of cyclin D1 and other molecular markers to cancer chemoprevention (1996) (60)
Cellular Moloney murine sarcoma (c-mos) sequences are hypermethylated and transcriptionally silent in normal and transformed rodent cells (1982) (60)
Failure of wild-type or a mutant form of protein kinase C-α to transform fibroblasts (1991) (59)
Expression of retroviral sequences and oncogenes in rat liver tumors induced by diethylnitrosamine. (1987) (58)
New bioactive polyphenols from Theobroma grandiflorum ("cupuaçu"). (2003) (58)
Antisense Targeting Protein Kinase C α and β1 Inhibits Gastric Carcinogenesis (2004) (58)
Molecular cloning of gene sequences regulated by tumor promoters and mitogens through protein kinase C (1987) (57)
Melittin shares certain cellular effects with phorbol ester tumour promoters (1979) (57)
Allelic exclusion and differentiation by protein kinase C-mediated signals in immature thymocytes. (2001) (57)
Abnormalities in the expression of cell cycle-related proteins in tumors of the small bowel. (1999) (56)
Cell and microsome mediated binding of 7,12-dimethylbenz(a)anthracene to DNA studied by fluorescence spectroscopy. (1978) (56)
Antioxidant and cytotoxic isoprenylated coumarins from Mammea americana. (2005) (56)
Comparative effects of aplysiatoxin, debromoaplysiatoxin, and teleocidin on receptor binding and phospholipid metabolism. (1983) (55)
1 – Interactions between Polycyclic Aromatic Hydrocarbons and Cellular Macromolecules (1978) (55)
Overexpression of protein kinase C-beta1 isoenzyme suppresses indomethacin-induced apoptosis in gastric epithelial cells. (2000) (55)
Protein synthesis in a subcellular system from Bacillus stearothermophilus. (1966) (54)
FLUORESCENCE STUDY OF THE PHYSICO‐CHEMICAL PROPERTIES OF A BENZO(A)PYRENE7,8‐DIHYDRODIOL9,10‐OXIDE DERIVATIVE BOUND COVALENTLY TO DNA (1979) (53)
Modulation of phagocytosis by tumor promoters and epidermal growth factor in normal and transformed macrophages. (1980) (53)
ULTRAVIOLET RADIATION STIMULATES THE RELEASE OF ARACHIDONIC ACID FROM MAMMALIAN CELLS IN CULTURE * (1985) (53)
Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer management. (2007) (53)
Molecular genetics of small bowel cancer. (1997) (53)
Tunnel vision (1996) (53)
Overexpression of cyclin D1 contributes to malignancy by up-regulation of fibroblast growth factor receptor 1 via the pRB/E2F pathway. (2003) (52)
Tumor promoter-induced adhesion of the DS19 clone of murine erythroleukemia cells. (1979) (52)
1 alpha,25-dihydroxyvitamin D3-induced regulation of protein kinase C gene expression during HL-60 cell differentiation. (1991) (52)
Design of a Retrovirus-Derived Vector for Expression and Transduction of Exogenous Genes in Mammalian Cells (1983) (51)
Isolation and characterization of a highly malignant variant of the SW480 human colon cancer cell line. (1992) (51)
Structure of 7,12-dimethylbenz(a)anthracene-guanosine adducts. (1976) (51)
Coding and conformational properties of oligonucleotides modified with the carcinogen N-2-acetylaminofluorene. (1970) (51)
Heterogeneity of murine erythroleukemia cells with respect to tumor promoter-mediated inhibition of cell differentiation. (1978) (51)
Studies on protein kinase C and colon carcinogenesis. (1987) (50)
Products obtained after in vitro reaction of 7,12-dimethylbenz[alpha]anthracene 5,6-oxide with nucleic acids. (1975) (49)
Modification of proteins by 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (nsc 79037) in vitro. (1973) (49)
Induction of chemotaxis in mouse peritoneal macrophages by phorbol ester tumor promoters. (1981) (49)
Inhibition of rodent protein kinase C by the anticarcinoma agent dequalinium. (1990) (49)
Effects of mevinolin and mevalonate on cell growth in several transformed cell lines (1986) (48)
Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of mdm2 amplification in human esophageal carcinomas (1993) (48)
Effects of cyclin E overexpression on cell growth and response to transforming growth factor beta depend on cell context and p27Kip1 expression. (1997) (47)
The growth inhibitory effect of actein on human breast cancer cells is associated with activation of stress response pathways (2007) (47)
Molecular cloning of TPAR1, a gene whose expression is repressed by the tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA). (1994) (47)
Growth of human melanocyte cultures supported by 12-O-tetradecanoylphorbol-13-acetate is mediated through protein kinase C activation. (1992) (47)
Benzophenones and biflavonoids from Garcinia livingstonei fruits. (2010) (46)
Proflavine binding to transfer ribonucleic acid, synthetic ribonucleic acids, and deoxyribonucleic acid. (1967) (46)
Increased levels of phorbin, c‐myc, and ornithine decarboxylase RNAs in human colon cancer (1990) (46)
Acyclic retinoid activates retinoic acid receptor beta and induces transcriptional activation of p21(CIP1) in HepG2 human hepatoma cells. (2004) (45)
Benzo[a]pyrene induction of extrachromosomal viral DNA synthesis in rat cells transformed by polyoma virus. (1983) (45)
Expression of multiple isoforms of protein kinase C in normal human colon mucosa and colon tumors and decreased levels of protein kinase C β and η mRNAs in the tumors (1994) (45)
Regulation of airway epithelial cell NF-kappa B-dependent gene expression by protein kinase C delta. (2003) (45)
Tumour promoters:Protein kinase, phospholipid and control of growth (1983) (45)
Effects of Acyclic Retinoid on Growth, Cell Cycle Control, Epidermal Growth Factor Receptor Signaling, and Gene Expression in Human Squamous Cell Carcinoma Cells (2004) (45)
Increased anxiety-related behaviour in Hint1 knockout mice (2011) (44)
Actein and a fraction of black cohosh potentiate antiproliferative effects of chemotherapy agents on human breast cancer cells. (2006) (44)
Expression of endogenous retrovirus-like sequences and cellular oncogenes during phenobarbital treatment and regeneration in rat liver. (1988) (44)
Overexpression of p27Kip1 inhibits the growth of both normal and transformed human mammary epithelial cells. (1998) (44)
Effects of cyclin D1 overexpression on G1 progression-related events. (1997) (44)
The Roles of JNK1 and Stat3 in the Response of Head and Neck Cancer Cell Lines to Combined Treatment with All trans‐retinoic Acid and 5‐Fluorouracil (2002) (43)
Decreased levels of protein kinase C enzyme activity and protein kinase C mRNA in primary colon tumors (1993) (43)
Modifications of ribonucleic acid by chemical carcinogens. I. In vitro modification of transfer ribonucleic acid by N-acetoxy-2-acetylaminofluorene. (1970) (43)
Modification of deoxyribonucleic acid by a diol epoxide of benzo[a]pyrene. Relation to deoxyribonucleic acid structure and conformation and effects on transfectional activity. (1979) (43)
Gene expression analysis of the mechanisms whereby black cohosh inhibits human breast cancer cell growth. (2007) (43)
Effects of 5-azacytidine on the progressive nature of cell transformation. (1985) (43)
Altered expression of retrovirus-like sequences and cellular oncogenes in mice fed methyl-deficient diets. (1989) (42)
Benzo[a]pyrene and other inducers of cytochrome P1-450 inhibit binding of epidermal growth factor to cell surface receptors. (1982) (42)
Growth inhibition of human melanoma‐derived cells by 12‐O‐tetradecanoyl phorbol 13‐acetate (1994) (42)
Control of melanin synthesis and secretion by B16/C3 melanoma cells (1982) (42)
Stimulation of growth of human melanocytes by tumor promoters. (1983) (41)
Effects of 5-azacytidine on methylation and expression of specific DNA sequences in C3H 10T1/2 cells (1984) (41)
Membrane and other Biochemical Effects of the Phorbol Esters and their Relevance to Tumor Promotion (1980) (41)
Activation of protein kinase C by tumor promoting phorbol esters, teleocidin and aplysiatoxin in the absence of added calcium. (1985) (41)
Effects of the tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate on newly synthesized proteins in mouse epidermis (1981) (41)
Cell culture studies provide new information on tumour promoters (1977) (41)
Structure-activity studies on the mechanism of action of miracil D. (1968) (41)
Differential effect of recombinant human leukocyte interferon on human leukemic and normal myeloid progenitor cells. (1982) (41)
Indicators of genotoxic exposure (1982) (40)
Signal transducers and activators of transcription 3 up-regulates vascular endothelial growth factor production and tumor angiogenesis in head and neck squamous cell carcinoma. (2007) (40)
Regulation of airway smooth muscle cyclin D1 transcription by protein kinase C-delta. (2002) (40)
Fidelity in the translation of messenger ribonucleic acids in mammalian subcellular systems. (1966) (40)
Oncogene-induced transformation of a rat embryo fibroblast cell line is enhanced by tumor promoters (1986) (40)
Strategies for inhibiting multistage carcinogenesis based on signal transduction pathways. (1988) (39)
Identification of a UV-induced trans-acting protein that stimulates polyomavirus DNA replication (1988) (39)
Differences in the transfer RNA's of normal liver and Novikoff hepatoma. (1969) (39)
Glucocorticoid inhibition of the fibrinolytic activity of tumor cells (1975) (39)
Phenylalanyl transfer ribonucleic acid synthetase activity associated with rat liver ribosomes and microsomes. (1973) (39)
Deficiency of the Y base in a hepatoma phenylalanine tRNA (1975) (38)
Overexpression of cyclin DI contributes to malignant properties of esophageal tumor cells by increasing VEGF production and decreasing Fas expression. (2002) (38)
Type C Virus from Cell Cultures of Chemically Induced Rat Hepatomas (1972) (38)
Patterns of Viral DNA Integration in Cells Transformed by Wild Type or DNA-Binding Protein Mutants of Adenovirus Type 5 and Effect of Chemical Carcinogens on Integration (1980) (37)
Phenotypic properties and tumor promotor-induced alterations in rat embryo cells transformed by adenovirus. (1979) (37)
Effects of 5-azacytidine on expression of endogenous retrovirus-related sequences in C3H 10T1/2 cells (1986) (37)
Tumour promoters enhance anchorage-independent growth of adenovirus-transformed cells without altering the integration pattern of viral sequences (1979) (37)
PM-3, a benzo-gamma-pyran derivative isolated from propolis, inhibits growth of MCF-7 human breast cancer cells. (2001) (37)
Stability of Ribosomes and Ribosomal Ribonucleic Acid from Bacillus stearothermophilus (1967) (37)
Overexpression of protein kinase C β1 in the SW480 colon cancer cell line growth suppression (1995) (37)
Overexpression of CDC25B overrides radiation-induced G2-M arrest and results in increased apoptosis in esophageal cancer cells. (2001) (37)
Template activity of calf thymus DNA modified by a dihydrodiol epoxide derivative of benzo[a]pyrene. (1977) (37)
Transformation by a ras oncogene causes increased expression of protein kinase C-alpha and decreased expression of protein kinase C-epsilon. (1990) (36)
Activation of protein kinase G Increases the expression of p21CIP1, p27KIP1, and histidine triad protein 1 through Sp1. (2008) (36)
Epidermal growth factor, like tumor promoters, enhances viral and radiation-induced cell transformation. (1981) (36)
Nonsteroidal Anti-inflammatory Drug Use Associated with Reduced Incidence of Adenocarcinomas of the Esophagus and Gastric Cardia that Overexpress Cyclin D1 (2004) (36)
HINT1 inhibits β‐catenin/TCF4, USF2 and NFκB activity in human hepatoma cells (2009) (35)
NEOPLASMS Malignant: National cancer institute workshop on tumor promotion and cofactors in carcinogenesis (1977) (35)
Enhancement of major histocompatibility class I protein synthesis by DNA damage in cultured human fibroblasts and keratinocytes (1989) (35)
The HINT1 tumor suppressor regulates both γ-H2AX and ATM in response to DNA damage (2008) (35)
Factors influencing the expression of endogenous retrovirus-related sequences in the liver of B6C3 mice. (1987) (35)
Effect of N-2-acetylaminofluorene modification on the structure and template activity of DNA and reconstituted chromatin. (1977) (35)
Miracil D: an inhibitor of ribonucleic acid synthesis in Bacillus subtilis. (1965) (35)
Temperature-sensitive mutants of chemically transformed epithelial cells. (1975) (34)
Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells. (2005) (34)
Expression of phospholipases γ1, β1, and δ1 in primary human colon carcinomas and colon carcinoma cell lines (1995) (34)
Changes in expression of oncogenes and endogenous retroviral-like sequences during colon carcinogenesis. (1988) (34)
Celecoxib‐induced growth inhibition in SW480 colon cancer cells is associated with activation of protein kinase G (2007) (34)
ABSOLUTE CONFIGURATION OF A RIBONUCLEIC ACID ADDUCT FORMED IN VIVO BY METABOLISM OF BENZO(A)PYRENE (1977) (34)
The α isoform of protein kinase C mediates phorbol ester-induced growth inhibition and p21cip1 induction in HC11 mammary epithelial cells (1999) (33)
Identification of a distinct phase during melanogenesis that is sensitive to extracellular pH and ionic strength (1980) (33)
Miracil D: effects on nucleic acid synthesis, protein synthesis, and enzyme induction in Escherichia coli. (1967) (33)
Changes in expression of cellular oncogenes and endogenous retrovirus-like sequences during hepatocarcinogenesis induced by a peroxisome proliferator. (1991) (33)
Exisulind and related compounds inhibit expression and function of the androgen receptor in human prostate cancer cells. (2003) (33)
Inhibition of the growth of glioblastomas by CGP 41251, an inhibitor of protein kinase C, and by a phorbol ester tumor promoter. (1996) (33)
Identification of ultraviolet-inducible proteins that bind to a TGACAACA sequence in the polyoma virus regulatory region. (1990) (32)
Effects of regulatory domains of specific isoforms of protein kinase C on growth control and apoptosis in MCF-7 breast cancer cells. (2003) (32)
Enhancement of macrophage-induced cytotoxicity by phorbol ester tumor promoters. (1981) (32)
Separation of ribonucleic acids by polyacrylamide gel electrophoresis. (1968) (32)
Effects of teleocidin and the phorbol ester tumor promoters on cell transformation, differentiation, and phospholipid metabolism. (1982) (32)
Modification of ribonucleic acid by chemical carcinogens. VI. Effect of N-2-acetylaminofluorene modification of guanosine on the codon function of adjacent nucleosides in oligonucleotides. (1974) (32)
Altered expression of cyclins and c-fos in R6 cells that overproduce PKC epsilon. (1995) (32)
Proflavine inhibition of protein synthesis. (1967) (31)
Chemical carcinogens and RNA. (1971) (31)
Carcinogen induced asynchronous replication of polyoma DNA is mediated by a trans-acting factor. (1986) (31)
Cellular uptake and localization of fluorescent derivatives of phorbol ester tumor promoters. (1985) (30)
Alterations in specific transfer ribonucleic acids in a spectrum of hepatomas. (1971) (30)
Carcinogen- and radiation-transformed C3H 10T1/2 cells contain RNAs homologous to the long terminal repeat sequence of a murine leukemia virus. (1982) (30)
Fidelity during translation of the genetic code. (1966) (30)
Mode of Action of Miracil D (1971) (30)
Cell Proliferation, Apoptosis, and Expression of Cyclin D1 and Cyclin E as Potential Biomarkers in Tamoxifen-Treated Mammary Tumors (2003) (30)
Synergistic Effects of Acyclic Retinoid and OSI-461 on Growth Inhibition and Gene Expression in Human Hepatoma Cells (2004) (30)
Indirect immunofluorescent localization of benzo[a]pyrene adducted to nucleic acids in cultured mouse keratinocyte nuclei. (1982) (30)
A self-assembling protein kinase C inhibitor. (1991) (29)
Treatment of human glioblastoma cells with the staurosporine derivative CGP 41251 inhibits CDC2 and CDK2 kinase activity and increases radiation sensitivity. (1998) (29)
Histidine Triad Nucleotide-binding Protein 1 Up-regulates Cellular Levels of p27KIP1 by Targeting ScfSKP2 Ubiquitin Ligase and Src* (2009) (29)
Growth inhibition induced by Ro 31-8220 and calphostin C in human glioblastoma cell lines is associated with apoptosis and inhibition of CDC2 kinase. (1998) (29)
Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells. (2006) (29)
Interferon inhibits melanogenesis in B-16 mouse melanoma cells. (1981) (29)
DNA--benzo[a]pyrene adducts formed in a Salmonella typhimurium mutagenesis assay system. (1979) (29)
Fidelity in protein synthesis. The role of the ribosome. (1968) (29)
Toxicity, cell proliferation, and carcinogenesis (1992) (28)
Overexpression of protein kinase C beta 1 in the SW480 colon cancer cell line causes growth suppression. (1995) (28)
Coding Ambiguity in Cell-Free Extracts of Chlamydomonas (1963) (28)
The Chemistry of Polycyclic Aromatic Hydrocarbon-DNA Adducts (1980) (28)
POLYPEPTIDE SYNTHESIS IN A SUBCELLULAR SYSTEM DERIVED FROM THE L-1210 MOUSE ASCITES LEUKEMIA. (1964) (28)
Effects of asbestos on epithelioid cell lines. (1978) (28)
Benzo(a)pyrene 7,8-dihydrodiol-9,10-oxide modification of DNA: relation to chromatin structure and reconstitution. (1978) (28)
Stimulation of prostaglandin production and choline turnover in HeLa cells by lyngbyatoxin A and dihydroteleocidin B. (1981) (27)
Induction of asynchronous replication of polyoma DNA in rat cells by ultraviolet irradiation and the effects of various inhibitors. (1987) (27)
Glucocorticoids and benzo(a)pyrene have opposing effects on EGF receptor binding (1981) (27)
Increased expression of the P 27 KIP 1 protein in human esophageal cancer cell lines that over-express cyclin D 1 (1997) (27)
The protein kinase C β–specific inhibitor LY379196 blocks TPA‐induced monocytic differentiation of HL60 cells the protein kinase C β–specific inhibitor LY379196 blocks TPA‐induced monocytic differentiation of HL60 cells (2000) (27)
Abnormalities in Cell Cycle Control in Cancer and Their Clinical Implications (1998) (27)
Biosynthetic studies of the Y base in yeast phenylalanine tRNA. Incorporation of guanine. (1973) (27)
Structure of the "peroxy-Y base" from liver tRNA Phe . (1971) (26)
Current concepts on mechanisms of chemical carcinogenesis. (1978) (26)
The history of Cancer Research: introducing an AACR Centennial series. (2008) (26)
Modifications of ribonucleic acid by chemical carcinogens. Modification of Escherichia coli formylmethionine transfer ribonucleic acid with N-acetoxy-2-acetylaminofluorene. (1972) (26)
Biochemical effects of the modification of nucleic acids by certain polycyclic aromatic carcinogens. (1979) (26)
Frequent K-ras mutations in small bowel adenocarcinomas (2005) (26)
Antisense targeting protein kinase C alpha and beta1 inhibits gastric carcinogenesis. (2004) (26)
Synthetic RNA-dependent DNA Polymerase Activity in Normal Rat Liver and Hepatomas (1972) (25)
Quantitative differences in proline tRNA content of rat liver and granulation tissue. (1970) (25)
Comparative Ability of Hycanthone and Miracil D to Interact with DNA (1971) (25)
Effects of a novel NF‐κB inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), on growth, apoptosis, gene expression, and chemosensitivity in head and neck squamous cell carcinoma cell lines (2006) (25)
Overexpression of PKCε in R6 fibroblasts causes increased production of active TGFβ (1998) (25)
Enhancement of cell proliferation in low calcium medium by tumor promoters. (1981) (25)
Expression of long terminal repeat (LTR) sequences in carcinogen-induced murine skin carcinomas. (1985) (25)
High-pressure liquid chromatography of carcinogen-nucleoside conjugates: separation of 7,12-dimethylbenzanthracene derivatives. (1976) (25)
Structure of the fluorescent nucleoside of yeast phenylalanine transfer ribonucleic acid. (1975) (25)
Modifications of ribonucleic acid by chemical carcinogens. 3. Template activity of polynucleotides modified by N-acetoxy-2-acetylamino-fluorene. (1971) (25)
Evidence that the ras oncogene-encoded p21 protein induces oocyte maturation via activation of protein kinase C. (1992) (25)
Cellular targets and host genes in multistage carcinogenesis. (1984) (24)
Effect of recombinant human fibroblast interferon and mezerein on growth, differentiation, immune interferon binding and tumor associated antigen expression in human melanoma cells. (1986) (24)
The scientific basis for carcinogen detection and primary cancer prevention (1981) (24)
The role of protein kinase C in growth control and the concept of carcinogenesis as a progressive disorder in signal transduction. (1990) (24)
The activation of protein kinase C by the polyphosphoinositides phosphatidylinositol 4,5‐diphosphate and phosphatidylinositol 4‐monophosphate (1987) (24)
A phorbol ester tumor promoter induces changes in the expression of immunoglobulins and DR antigens in human lymphoblastoid cells. (1982) (24)
Coding properties of sRNA containing 8-azaguanine. (1965) (24)
The sulindac derivatives OSI-461, OSIP486823, and OSIP487703 arrest colon cancer cells in mitosis by causing microtubule depolymerization (2006) (23)
Effects of H. pylori infection of gastric epithelial cells on cell cycle control. (2001) (23)
Phenotypic effects of overexpression of PKCβ1 in rat liver epithelial cells (1989) (23)
Growth factor‐induced DNA synthesis in cells that overproduce protein kinase C (1990) (23)
The regulatory domain of protein kinase C beta 1 contains phosphatidylserine- and phorbol ester-dependent calcium binding activity. (1993) (23)
Effects of tumor promoters and extracellular calcium on the growth of normal, transformed and temperature sensitive rat liver epithelial cells. (1980) (23)
Effects of 8-methoxypsoralen and ultraviolet light A on EGF receptor (HER-1) expression. (1988) (22)
Phorbol ester induced prostaglandin synthesis and [3H]-TPA metabolism by TPA-sensitive and TPA-resistant Friend erythroleukemia cells. (1979) (22)
Studies on rat liver phenylalanyl transfer ribonucleic acid synthetase. II. Further purification, substrate specificity, and effects of substrates on heat inactivation. (1973) (22)
Evidence that oocyte maturation induced by an oncogenic ras-p21 protein and insulin is mediated by overlapping yet distinct mechanisms. (1992) (22)
Altered regulation of a major substrate of protein kinase C in rat 6 fibroblasts overproducing PKC beta I. (1992) (21)
Studies on the effect of cortisone on rat liver transfer ribonucleic acid. (1969) (21)
TPA-resistance in Friend erythroleukemia cells: role of membrane lipid fluidity. (1981) (21)
CP248, a derivative of exisulind, causes growth inhibition, mitotic arrest, and abnormalities in microtubule polymerization in glioma cells. (2002) (21)
Changes in epidermal growth factor receptors associated with adenovirus transformation, chemical carcinogen transformation and exposure to a phorbol ester tumor promoter. (1980) (20)
Staphylococcal delta-hemolysin inhibits cellular binding of epidermal growth factor and induces arachidonic acid release. (1980) (20)
A factor present in fetal calf serum enhances oncogene-induced transformation of rodent fibroblasts (1987) (19)
The monitoring of DNA adducts as an approach to carcinogen detection. (1983) (19)
Plasminogen activator synthesis accompanying chemical carcinogen‐induced in vitro transformation of syrian hamster and guinea‐pig fetal cells (1980) (19)
Comparative studies on mammalian and yeast phenylalanine transfer ribonucleic acids. (1971) (19)
Cloning and characterization of DIP1, a novel protein that is related to the Id family of proteins. (2000) (19)
Studies on rat liver phenylalanyl transfer ribonucleic acid synthetase. I. Purification, stabilization, and complex formation. (1971) (19)
Hybrid recombinant human leukocyte interferon inhibits differentiation in murine B-16 melanoma cells. (1984) (18)
Overexpression of p21Cip1 or p27Kip1 in the promyelocytic leukemia cell line HL60 accelerates its lineage-specific differentiation. (1999) (18)
Miracil D: effect on the viscosity of DNA. (1969) (18)
Conformation of dinucleoside monophosphates modified with benzo[a]pyrene-7,8-dihydrodiol 9,10-oxide as measured by circular dichroism. (1978) (18)
Expression of phospholipases gamma 1, beta 1, and delta 1 in primary human colon carcinomas and colon carcinoma cell lines. (1995) (18)
Inducible cellular responses to ultraviolet light irradiation and other mediators of DNA damage in mammalian cells (2004) (18)
Design of a selectable reporter for the detection of mutations in mammalian simple repeat sequences. (1995) (17)
Novel revertants of H-ras oncogene-transformed R6-PKC3 cells (1992) (17)
In vitro inhibition of rat brain protein kinase C by rhodamine 6G. Profound effects of the lipid cofactor on the inhibition of the enzyme. (1987) (17)
BENZO(A)PYRENE DIOL EPOXIDES AS INTERMEDIATES IN NUCLEIC ACID BINDING IN VITRO AND IN VIVO (1976) (17)
Structural and functional studies of protein kinase C. (1988) (17)
The use of agarose in the determination of anchorage-independent growth (1979) (17)
Transformation of a rat epithelial-like cell line by murine sarcoma virus. (1972) (17)
Quantitation of exposure to benzo[a]pyrene with monoclonal antibodies. (1985) (17)
A comparison of techniques for introducing macromolecules into living cells. (1993) (16)
Failure of wild-type or a mutant form of protein kinase C-alpha to transform fibroblasts. (1991) (16)
Inhibition of respiration by a phorbol ester tumor promoter in murine cultured cells. (1982) (16)
Exisulind and CP248 induce growth inhibition and apoptosis in human esophageal adenocarcinoma and squamous carcinoma cells. (2003) (15)
Studies on transfer RNA population during liver regeneration in the rat. (1970) (15)
Reticulocyte Protein Synthesis: Response of Ribosome Fractions to Polyuridylic Acid (1963) (15)
Induction of erythroleukemia cell adhesion by plant diterpene tumour promoters: a quantitative study and correlation with in vivo activities. (1981) (15)
Glycopeptides from epithelial cell mutants: Temperature sensitive for the transformation phenotype (1977) (15)
Comparative Studies on the Genetic Code (1963) (15)
Characterization of a specific form of protein kinase C overproduced by a C3H 10T1/2 cell line. (1990) (15)
Cyclin D1 overexpression is more prevalent in non-Caucasian breast cancer. (2001) (15)
Binding of K- and non-K-region arene oxides and phenols of polycyclic hydrocarbons to polyguanylic acid. (1976) (14)
Fidelity in protein synthesis: proline miscoding in a thermophile system. (1965) (14)
Calcium reduces the increased fecal 1,2-sn-diacylglycerol content in intestinal bypass patients: a possible mechanism for altering colonic hyperproliferation. (1994) (14)
The role of protein kinase C in signal transduction, growth control and lipid metabolism. (1997) (14)
Specific protein production during melanogenesis in B16/C3 melanoma cells (1983) (14)
Overexpression of protein kinase C beta I in a murine keratinocyte cell line produces effects on cellular growth, morphology and differentiation. (1994) (14)
Activated Checkpoint Kinase 2 Expression and Risk for Oral Squamous Cell Carcinoma (2007) (14)
Modulation of adenovirus transformation by thyroid hormone. (1983) (13)
Polyamine inhibition of estrogen receptor (ER) DNA-binding and ligand-binding functions (1998) (13)
Studies on the mechanism by which a tumor promoter inhibits binding of epidermal growth factor to cellular receptors. (1980) (13)
Identification of an intracellular protein that specifically interacts with photoaffinity-labeled oncogenic p21 protein. (1989) (13)
Results and speculations related to recent studies on mechanisms of tumor promotion. (1982) (13)
Overexpression of Phosphatidylinositol Synthase Enhances Growth and G1 Progression in NIH3T3 cells (2002) (13)
Distribution of the c-myc oncoprotein in normal and neoplastic tissues of the rat colon. (1988) (13)
Genetic factors in Escherichia coli that affect cell killing and mutagenesis induced by benzo(a)pyrene-7,8-dihydrodiol 9,10-oxide. (1980) (13)
Sulindac Sulfide and Exisulind Inhibit Expression of the Estrogen and Progesterone Receptors in Human Breast Cancer Cells (2006) (13)
Protein Kinase C in Neoplastic Cells (1991) (12)
The effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on phospholipid metabolism of human epidermal keratinocytes in culture. (1986) (12)
Binding of phorbol dibutyrate and epidermal growth factor to cultured human epidermal cells. (1983) (12)
Factors influencing the expression of endogenous retrovirus‐like sequences in rat 6 cells (1990) (12)
Effects of phorbol ester tumor promoters in platelet aggregation and platelet production of cyclooxygenase products. (1979) (12)
Protein kinase, phospholipid and control of growth. (1983) (12)
Effect of tumor promoters on sarc gene expression in normal and transformed chick embryo fibroblasts. (1981) (11)
Inducible cellular responses to DNA damage in mammalian cells. (1986) (11)
When do carcinogen-treated 10T1/2 cells acquire the commitment to form transformed foci? (1982) (11)
Uptake of the tumor promoting agent 12-0-tetradecanoyl-phorbol-13-acetate by HeLa cells. (1978) (11)
Erratum: Regulation of airway epithelial cell NF-κB-dependent gene expression by protein kinase Cδ (Journal of Immunology (2003) 170 (5681-5689)) (2003) (10)
Use of epithelial cell cultures for studies on the mechanism of transformation by chemical carcinogens (1975) (10)
Carcinogen Policy at EPA (1983) (10)
p21 ras proteins and guanine nucleotides modulate the phosphorylation of 36- and 17-kilodalton mitochondria-associated proteins. (1986) (10)
Interactions between initiating chemical carcinogens, tumor promoters, and adenovirus in cell transformation. (1980) (10)
Effects of the ionic environment on modification of yeast tyrosine transfer ribonucleic acid with N-acetoxy-2-acetylaminofluorene. (1974) (10)
Antisense to Cyclin Dl Inhibits the Growth and Tumorigenicity of Human Colon Cancer Cells1 (1997) (9)
Effects of increased expression of protein kinase C on radiation-induced cell transformation. (1994) (9)
Tumor promoters alter the temporal program of adenovirus replication in human cells (1981) (9)
Inhibition of phorbol ester-receptor binding by a factor from human serum (1982) (9)
The alpha isoform of protein kinase C mediates phorbol ester-induced growth inhibition and p21cip1 induction in HC11 mammary epithelial cells. (1999) (9)
Suppression of mitogenic activity by stable expression of the regulatory domain of PKC beta. (1994) (9)
A novel, plasmid-based system for studying gene rearrangements in mammalian cells (1991) (9)
Binding of protein kinase C to napthalenesulfonamide- and phenothiazine-agarose columns: evidence for direct interactions between protein kinase C and cationic amphiphilic inhibitors of the enzyme. (1987) (9)
Preferential inhibition of the synthesis of 45S ribosomal rna precursor by N-acetoxyacetylaminofluorene in rat liver epithelial cultures. (1976) (9)
Overexpression of CDC 25 B Overrides Radiation-induced G 2M Arrest and Results in Increased Apoptosis in Esophageal Cancer Cells 1 (2001) (9)
The modulation of growth by HMBA in PKC overproducing HT29 colon cancer cells. (1991) (8)
SPERMINE INHIBITION OF POLYPEPTIDE SYNTHESIS IN A SUBCELLULAR SYSTEM DERIVED FROM THE L1210 MOUSE ASCITES LEUKEMIA. (1965) (8)
Nonsteroidal Anti-inflammatory Drug Use Associated with Reduced Incidence of Adenocarcinomas of the Esophagus and Gastric Cardia that Overexpress Cyclin D1: A Population-Based Study (2004) (8)
Modifications of ribonucleic acid by chemical carcinogens. II. In vivo reaction of N-2-acetylaminofluorene with rat liver ribonucleic acid. (1970) (8)
Effects of triiodothyronine and tamoxifen on cell transformation induced by an activated c-Ha-ras oncogene. (1989) (8)
The role of protein kinase C in signal transduction and cellular transformation. (1990) (8)
Isolation and charactrization of a morphologic variant of chinese hamster (CHO) cells (1980) (8)
The Origins of Human Cancer : Molecular Mechanisms of Carcinogenesis and Their Implications for Cancer Prevention and Treatmentâ€ ” Twenty-seventh G (2006) (8)
Amphiphilic cationic peptides mediate cell adhesion to plastic surfaces (1985) (8)
AMINO ACID CODING IN A SUBCELLULAR SYSTEM DERIVED FROM THE L1210 MOUSE ASCITES LEUKEMIA. (1964) (7)
Application of biological markers to the study of lung cancer causation and prevention. (1988) (7)
Cyclin D1 expression in the intestinal mucosa and tumors of Apc1638N mice. (2003) (7)
Codon Recognition by Enzymatically Mischarged Valine Transfer Ribonucleic Acid (1969) (7)
Evaluating substances for promotion, cofactor effects and synergy in the carcinogenic process. (1980) (7)
Chronic Helicobacter pylori Infection Induces an Apoptosis-Resistant Phenotype Associated with Decreased Expression of p27kip1 (2000) (7)
p16Ink4a is Overexpressed in H. pylori‐Associated Gastritis and is Correlated with Increased Epithelial Apoptosis (2003) (7)
A possible role of transfer RNA in the mechanism of carcinogenesis. (1968) (7)
Hint 1 Inhibits Growth and Activator Protein-1 Activity in Human Colon Cancer Cells (2007) (7)
Transformation by a ras Oncogene Causes Increased Expression of Protein Kinase C-a and Decreased (1990) (6)
Role of protein kinase C in regulation of gene expression and relevance to tumor promotion. (1987) (6)
Induction of apoptosis by sulindac sulfide in HL60 cells is enhanced by p21CiP1 or p27KiP1. (2001) (6)
Two polychlorinated hydrocarbons cause phospholipid‐dependent protein kinase C activation in vitro in the absence of calcium (1991) (6)
Dip1 inhibits growth and gene transcription in MCF-7 breast cancer cells. (2007) (6)
Overexpression of Cyclin D 1 Contributes to Malignancy by Up-Regulation of Fibroblast Growth Factor Receptor 1 via the pRB / E 2 F Pathway 1 (2003) (6)
The human interferons: from the past and into the future. (1984) (6)
Nonsteroidal Anti-inflammatory Drug Use Associated with Reduced Incidence of Adenocarcinomas of the Esophagus and Gastric Cardia that Overexpress Cyclin D 1 : A Population-Based Study (2004) (6)
Growth Inhibition of Human Hepatoma Cells by Acyclic Retinoid Is Associated with Induction of p 21 CIP 1 and Inhibition of Expression of Cyclin D 11 (2002) (6)
Synergistic interactions between chemical carcinogens, tumor promoters, and viruses and their relevance to human liver cancer. (1989) (6)
IDENTIFICATION OF CARCINOGEN-DNA ADDUCTS BY IMMUNOASSAYS (1983) (6)
Select Cyclic Nucleotide Phosphodiesterase Inhibitors in Colon Tumor Chemoprevention and Chemotherapy (2004) (6)
N-alpha-Tosyl-L-lysine chloromethyl ketone and N-alpha-tosyl-L-phenylalanine chloromethyl ketone inhibit protein kinase C. (1985) (6)
Cigarette smoking and its fingerprint on DNA. (1988) (6)
( 2 )-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser 1046 / 1047 by p 38 MAPK in colon cancer cells (2009) (6)
Genomic changes in glioblastoma cell lines detected by comparative genomic hybridization (2004) (6)
Current Concepts of Tumor Promotion by Phorbol Esters and Related Compounds (1986) (5)
Enucleation of mammalian cells in suspension. (1976) (5)
Inhibition of Heucobacter pylori growth by sulindac (2000) (5)
The HINT1 tumor suppressor regulates both (cid:2) -H2AX and ATM in response to DNA damage (2008) (5)
The Contributions of Molecular Biology to Cancer Epidemiology a (1995) (5)
Chemical-viral interactions and multistep aspects of cell transformation. (1980) (5)
Carcinogen-DNA adducts in mutagenesis assays. (1981) (5)
Transduction of the human insulin gene via retroviral vectors fails to yield spliced transcripts. (1989) (5)
Effects of a fecapentaene on protein kinase C. (1991) (5)
Activation of Protein Kinase G Increases the Expression of p 21 CIP 1 , p 27 KIP 1 , and Histidine Triad Protein 1 through Sp 1 (2008) (5)
The phorbol ester TPA markedly enhances the binding of calcium to the regulatory domain of protein kinase C beta 1 in the presence of phosphatidylserine. (1995) (5)
Nitropyrenes are inducers of polyoma viral DNA synthesis. (1987) (5)
Effects of specific fatty acids on cell transformation induced by an activated c-H-ras oncogene. (1990) (4)
The roles of specific isoforms of protein kinase C in growth control and human colon cancer. (1991) (4)
Cell proliferation: concluding remarks (1993) (4)
Extraction Methods Play a Critical Role in Chemical Profile and Biological Activities of Black Cohosh (2008) (4)
Down-regulation of the cGMP/PKG pathway in primary human colon cancers and cancer cell lines (2005) (4)
Cell culture studies on the mechanism of action of chemical carcinogens and tumor promoters. (1985) (4)
p16Ink4a is overexpressed in H. pylori-associated gastritis and is correlated with increased epithelial apoptosis. (2001) (4)
Studies on the mechanism of action of protein kinase C and the isolation of molecular clones encoding the enzyme. (1986) (4)
Altered expression of protein kinase C, lck, and CD45 in a 12-O-tetradecanoylphorbol-13-acetate-dependent leukemic T-cell variant that expresses a high level of interleukin-2 receptor (1992) (4)
Deregulated Expression of 27 KiP 1 in Human Breast Cancers 1 (2005) (4)
Cell regulation and cancer. (1979) (4)
Effects of various chemical agents on the transformation of rat fibroblasts by an activated c‐Ha‐ras oncogene (1989) (4)
Carcinogenesis as a multistage process--experimental evidence. (1982) (4)
Phenotypic effects of overexpression of PKC beta 1 in rat liver epithelial cells. (1989) (4)
Activation of Protein Kinase G Upregulates Expression of 15-Lipoxygenase-1 in Human Colon Cancer Cells (2005) (3)
Growth Inhibition, Enhancement of Intercellular Adhesion, and Increased Expression of Carcinoembryonic Antigen by Overexpression of Phosphoinositides‐specific Phospholipase C β1 in LS174T Human Colon Adenocarcinoma Cell Line (1998) (3)
Carcinogens can induce alternate conformations in nucleic acid structure. (1983) (3)
Adductsof N-Acetyl-2-aminofluoreneby Single Strand specific Endonucleases1 (1977) (3)
Isolation of a complementary DNA encoding the catalytic subunit of protein kinase A and studies on the expression of this sequence in rat hepatomas and regenerating liver. (1990) (3)
Phorbol esters produce a delay in the expression of melanogenesis by b-16 melanoma cells. Abstr. (1978) (3)
Filamentous forms of enveloped A particles in cell cultures from chemically induced rat hepatomas. (1973) (3)
Report of the Eighth International Symposium of the Foundation for Promotion of Cancer Research: basic and clinical research in colorectal cancer. (1995) (3)
Mast cells provide a "HINT" to the function of an exotic nucleotide. (2004) (3)
Initial cellular targets and eventual genomic changes in multistage carcinogenesis. (1984) (3)
c-K-ras transformed rat enterocytes (R1) are more sensitive than normal enterocytes (IEC18) to growth inhibition and appptosis-induced by sulindac sulfone and nimesulid (1998) (3)
The Role of Environmental Chemicals in Human Cancer Causation (1992) (3)
Oncogene-Induced Transformation ofaRatEmbryoFibroblast Cell LineIsEnhanced byTumorPromoters (1986) (2)
Herbimycin A induces G1 arrest through accumulation of p27(Kip1) in cyclin D1-overexpressing fibroblasts. (2000) (2)
Diagnostic detection of mutant ras genes in minor cell populations. (1995) (2)
Growth limitation of BHK-21 cells and its relation to folate metabolism (1979) (2)
Polyuridylic acid stimulation of phenylalanine incorporation in animal cell extracts. (1962) (2)
Chemical Carcinogens and RNA1 (1971) (2)
H pylori induces p21cip1 & inhibits G1/S progression while inducing apoptosis in synchronized gastric epithelial cells (1998) (2)
Molecular Mechanisms of Tumor Promotion and Multistage Carcinogenesis: Relevance to Breast Cancer a (1986) (2)
Interaction of N-2-Acetylaminofluorene with RNA (1971) (2)
Genetic targets in multistage carcinogenesis. (1985) (2)
Infectivity and reconstitution of TMV RNA modified with N-acetoxy-2-acetylaminofluorene or benzol [a] pyrene 7,8-dihydrodiol 9,10 oxide. (1980) (2)
Interaction of SEWA sarcoma cell proteins with the intracisternal A‐type particle long terminal repeat dna sequence (1992) (2)
Restriction fragment length polymorphism of chromosome 3 (3p) and the epidermal growth factor receptor gene in human non-small cell lung carcinomas. (1990) (2)
[159] Description of nucleic acid coding for mammalian protein synthesis (1968) (2)
Cell culture systems for studying multifactor interactions in carcinogenesis. (1980) (2)
Exisulind and CP 248 induce growth inhibition and apoptosis in human esophageal adenocarcinoma and squamous carcinoma cells (2003) (2)
CP 248 , a Derivative of Exisulind , Causes Growth Inhibition , Mitotic Arrest , and Abnormalities in Microtubule Polymerization in Glioma Cells 1 (2002) (1)
Fecal diacylglycerol concentrations and calcium supplementation. (1995) (1)
Effects of5-Azacytidine on Expression ofEndogenous Retrovirus- Related Sequences inC3H 1OT1/2 Cells (1986) (1)
Growth and Structural Properties of Epithelial Cell Cultures Established from Normal Rat Liver and Chemically Induced 1 (1)
The possible role of cellular genes related to retroviruses in the process of chemical and radiation carcinogenesis. (1982) (1)
Polyphenolic compounds from the fruit garcinia strongly inhibit the growth of human colon cancer cells by G1/S arrest and apoptosis (2003) (1)
The novel tumor suppressor HINT1 plays a role in DNA repair (2008) (1)
AMINO ACID INCORPORATION INTO PROTEIN BY A CELL FREE SYSTEM FROM PLASMA CELL TUMORS. (1964) (1)
Molecular and cellular mechanisms of chemical carcinogenesis. (1976) (1)
Protein kinase C: implications for cancer prevention and treatment. (1992) (1)
Molecular Mechanisms of Multistage Carcinogenesis (1982) (1)
Alterations of Cell Surface Receptors and Expression of Cellular Oncogenes in the Liver of Rats Fed a Hypolipidemic Peroxisome Proliferator (1991) (1)
Differences between normal and transformed murine fibroblasts in the expression of various promoter/enhancer—chloramphenicol acetyltransferase constructs (1988) (1)
Modification of mitochondrial dna by a dihydrodiol-epoxide derivative of benzo(a)pyrene. Abstr. (1980) (1)
Proteins encoded by ras oncogenes stimulate or inhibit phosphorylation of specific mitochondrial membrane proteins. (1986) (1)
The apocalyptics: Science and the big cancer lie. By Edith Efron, Simon and Schuster, New York, 1984. 512 pages, $19.95 (1985) (1)
Protein Synthesis and the Genetic Code in Subcellular Systems Derived from Normal and Neoplastic Animal and Human Tissues. (1965) (1)
Molecular events in chemical carcinogenesis. (1976) (1)
The Roles of Specific Isoforms of Protein Kinase C (PKC) in Signal Transduction, Growth Control and Diacylglycerol Metabolism (1993) (1)
to Tumor Promotion Macrocyclic Plant Diterpene Esters and Other Agents Related Induction of Plasminogen Activator in Cultured Cells by Updated (2006) (0)
Studies on the Role of Protein Kinase C in Multistage Carcinogenesis and Their Relevance to Risk Extrapolation (1992) (0)
Abnormalities in Cell Cycle Control in Human Cancer and Their Relevance to Chemoprevention (2004) (0)
Role of DIP1, a Novel Id-Like Protein in Breast Cancer (2000) (0)
( 2 )-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells (2008) (0)
7 – Biochemical Effects of the Phorbol Ester Tumor Promoters and Their Implications for Polycyclic Aromatic Hydrocarbon Carcinogenesis (1981) (0)
Diadenosine tetraphosphate (Ap4A) produced by lysyl-tRNA synthetase may play a role in inhibiting the function of the HINT1 tumor suppressor in human colon cancer cells (2008) (0)
PKCI-1-ZINC (1996) (0)
Supplement II: Abstracts of the international symposium on Skin Carcinogenesis in man and in experimental models. Heidelberg, 29–31 October 1991 (pp S61–S88) (1991) (0)
Macrocyclic Plant Diterpene Esters and Other Agents Related Induction of Plasminogen Activator in Cultured Cells by (2006) (0)
R043: Effects of Green Tea Catechin on EGFR Signaling Pathways (2003) (0)
845 HINT1 IS A PROTEIN POTENTIALLY IMPLICATED IN LIVER REGENERATION (2009) (0)
Phorbol ester tumor promoters stimulate rapid release of choline from cell phospholipids. Abstr. (1980) (0)
Letter from I. Bernard Weinstein to Joshua Lederberg (1980) (0)
Phorbol esters and melittin alter arachidonic acid met- abolism and share other phenotypic effects on cells in culture. Abstr. (1979) (0)
Inhibition of CDC2 and CDK2 and radiosensitization of human glioblastoma cells by the staurosporine derivative CGP 41251 (1996) (0)
Expression of the cyclin-dependent kinase inhibitor p27kip1 is reduced in gastric epithelial cells of patients with helicobacter pylori-induced gastritis (2000) (0)
INDUCTION OF THE TRANSFORMED PHENOTYPE IN RAT FIBROBLASTS BY TRANSFECTION OF CHROMOSOMAL DNA EXTRACTED FROM POLYOMA TRANSFORMED RAT CELLS (1980) (0)
Technical Report Abstracts (1993) (0)
Patterns ofViral DNA Integration inCells Transformed by WildTypeorDNA-Binding Protein Mutants ofAdenovirus Type5andEffect ofChemical Carcinogens onIntegration (1980) (0)
Deregulated Expression of 27KiP1 in Human Breast Cancers1 (1997) (0)
A self-assembling protein kinase C inhibitor ( antineoplastic agent / synergism / hydrazone / lipophilic cation / prodrug ) (0)
Gastric Carcinogenesis Inhibits 1 β and α Antisense Targeting Protein Kinase C Updated (2004) (0)
in Rat Embryo Cells Transformed by Adenovirus Phenotypic Properties and Tumor Promoter-induced Alterations (2013) (0)
Pharmacology and molecular biology of cancer chemotherapy. (1970) (0)
Structure-Activity Studies on the Mechanism of Action of Miracil D 1 (2006) (0)
Protein Kinase C B Enhances Growth and Expression of Cyclin D1 in Human Breast Cancer Cells (2006) (0)
Proton pump inhibitors (PPI) reduce cell cycle abnormalities in Barrett's esophagus (BE) (1998) (0)
B-Dependent Gene Expression by Protein k Regulation of Airway Epithelial Cell NF-R. (2003) (0)
Protein ph~sphorylatio~ in isolated mitoc~o~dria and the efI'ects of protein kinase C (1986) (0)
Abstracts of papers presented at the Meeting on Phorbol Esters, May 11-May 14, 1978 (1978) (0)
Targeting receptor tyrosine kinases and multiple downstream signaling pathways by green tea catechin EGCG. (2007) (0)
Phenylacetate induces G1/S arrest and apoptosis in colon cancer cells but antagonizes S-phase specific chemotherapy (2003) (0)
BIOPHYSICALCHARACTERISTICS OFTHE RNA-CONTAINING BACTERIALVIRUSR17* (1963) (0)
Polypeptide synthesis and amino acid coding in subcellular systems derived from human and l1210 mouse ascites leukemia. Abstr. (1963) (0)
On cancer's track (1986) (0)
Kinases in Human Colon Carcinomas-dependent Protein 2 + Altered Levels of Protein Kinase C and Ca Updated (2006) (0)
Cells Associated with Altered Lipid Order in HT 29 Colon Cancer Activation of the Epidermal Growth Factor Receptor Is )-Epigallocatechin Gallate on − The Inhibitory Effect of ( Updated (2007) (0)
TumorPromoters Alter theTemporal ProgramofAdenovirus Replication inHumanCells (1981) (0)
The Role of Cyclin D1 Overexpression in Breast Cancer Progression (1995) (0)
Inhibition of c-H-ras oncogene induced transformation of rat embryo fibroblasts by cotransfected polynucleotides containing alternating purine-pyrimidine sequences. (1988) (0)
HINT1 inhibits proteasome-mediated degradation of p21CIP1 and p27KIP1 (2007) (0)
Increased Expression of p 27 Epithelial Cell Line Is Associated with Growth Inhibition and Overexpression of Cyclin E in the HC 11 Mouse Mammary Updated (2006) (0)
Antisense Targeting Protein Kinase C (cid:1) and (cid:2) 1 Inhibits Gastric Carcinogenesis (2004) (0)
Effects of 5-azacytidine on the progressive nature of cell transformation (1985) (0)
Structure-Activity Studies on the Mechanism of Action of Miracil D1 (2006) (0)
Fecal Diacyiglycerol Concentrations and Calcium Supplementation1 (1995) (0)
Expression of Endogenous Retro virus-li ke Sequences and Cellular Oncogenes during PhÃ©nobarbitalTreatment and Regeneration in Rat Liver1 (2006) (0)
Guanine nucleotides and ras p 21 proteins modulate phosphorylation of 36 kilodalton and 17 kilodalton proteins in subcellular fractions (1986) (0)
Modulation of melanogenesis by lectins and lectin inhibitors (1981) (0)
Effect of 12-O-tetradecanoyl-phorbol-13-acetate (TPA), mezerein and the calcium ionophore A23187 on newly synthesized proteins in mouse epidermis (1981) (0)
Overexpression of protein kianse C-b1 isoenzyme suppress indomethacin-induced apoptosis in gastric cancer cells (1999) (0)
82 ABLATION OF HISTIDINE TRIAD NUCLEOTIDE-BINDING PROTEIN-1 (HINT1) INCREASES SENSITIVITY TO HEPATOCELLULAR CARCINOMA (2008) (0)
Correction (1998) (0)
Epigallocatechin-3-gallate Inhibits Activation of HER-2 / neu and Downstream Signaling Pathways in Human Head and Neck and Breast Carcinoma Cells 1 (2003) (0)
Mechanisms of multistage chemical carcinogenesis and their relevance to respiratory tract cancer. (1985) (0)
EGCG inhibits critical pathways of signal transduction in human cancer cells. (2006) (0)
Formationof DNA Adductsin 1OT%MouseEmbryoFibroblastsIncubated with Benzo(a)pyreneor DihydrodiolOxide Derivatives1 (2006) (0)
PKCI-1-APO+ZINC (1996) (0)
c-Src plays a role in internalization of epidermal growth factor receptors (EGFR) induced by (-)-epigallocatechin gallate (EGCG) in SW480 colon cancer cells. (2008) (0)
32 HINT1 KNOCK-OUT MICE ARE RESISTANT TO HEPATIC ISCHEMIA/REPERFUSION INJURY (2009) (0)
Modulationof PhagoCytosisby Tumor Promotersand EpidermalGrowth Factor in Normaland TransformedMacrophages1 (2006) (0)
A phorbol ester tumor promoter inhibits respiration in cell culture. Abstr. (1982) (0)
Preferential inhibition of protein kianse C-b1 isoenzyme medicates indomethacin-induced apoptosis of gastric epithelial cells (1999) (0)
PKIX Working Group Michael Myers ( VeriSign ) Internet Draft Xiaoyi Liu (1999) (0)
Cell cycle abnormalities in small bowel tumors (1998) (0)
New Insights into Tumor Promotion from Molecular Studies of Protein Kinase C (1988) (0)
The genetic code of mammalian cells. Abstr. (1964) (0)
Advances in Brief Amplification and Expression of the Human Cyclin D Gene in Esophageal Cancer 1 (2006) (0)
EGCG inhibits activation of the IGF/IGF-1R system in human colon cancer and hepatoma cells (2006) (0)
Kinase C B-Dependent Gene Expression by Protein κ Regulation of Airway Epithelial Cell (2003) (0)
Interactions Between Cell Cycle Control Proteins and the Androgen Receptor in Prostate Cancer (2003) (0)
BIOPHYSICAL CHARACTERISTICS OF THE RNA-CONTAINING BACTERIAL VIRUS R17* (1963) (0)
TITLE : Interactions Between Cell Cycle Control Proteins and the Androgen Receptor in Prostate Cancer PRINCIPAL INVESTIGATOR : (0)

This paper list is powered by the following services:

Other Resources About I. Bernard Weinstein

en.wikipedia.org

What Schools Are Affiliated With I. Bernard Weinstein?

I. Bernard Weinstein is affiliated with the following schools:

I. Bernard Weinstein's Academic­Influence.com Rankings